- Home
- ASND vs ONTO Comparison
ASND vs ONTO Comparison
Compare ASND & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | ONTO |
|---|---|---|
| Founded | 2006 | 1940 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 10.9B |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ASND | ONTO |
|---|---|---|
| Price | $225.73 | $189.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 8 |
| Target Price | ★ $278.80 | $229.38 |
| AVG Volume (30 Days) | 713.8K | ★ 862.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.78 |
| Revenue | N/A | N/A |
| Revenue This Year | $98.02 | $26.63 |
| Revenue Next Year | $43.13 | $16.26 |
| P/E Ratio | ★ N/A | $66.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $124.06 | $89.40 |
| 52 Week High | $248.60 | $232.49 |
Technical Indicators
Market Signals| Indicator | ASND | ONTO |
|---|---|---|
| Relative Strength Index (RSI) | 46.01 | 42.61 |
| Support Level | $190.49 | $178.40 |
| Resistance Level | $229.94 | $229.81 |
| Average True Range (ATR) | 9.30 | 10.36 |
| MACD | -1.48 | -3.59 |
| Stochastic Oscillator | 21.99 | 25.80 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.